Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Concentrix Sees Q4 Adj EPS $2.85-$2.96 vs $3.32 Est; Sees Sales $2.525B-$2.550B vs $2.525B Est

Author: Benzinga Newsdesk | September 25, 2025 03:06pm
Concentrix (NASDAQ: CNXC) is looking for Q4 Adj EPS of $2.85-$2.96 vs $3.32 analyst estimate. sees sales of $2.525 billion-$2.550 billion vs $2.525 billion analyst estimate.

Posted In: CNXC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist